Yangzhong Zhou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Top Venues

Journal for immunotherapy of cancer

Rheumatology and immunology research

Lupus science & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiang Li, Yangzhong Zhou, Bing Xu, Yunhe Qin, Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li
Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (1) (2024)
Hui Jiang, Yangzhong Zhou
The vanishing touch: Unveiling the tuft erosion in scleroderma. Rheumatology and immunology research 5 (1) (2024)
Xiang Li, Yangzhong Zhou, Bing Xu, Yunhe Qin, Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li
Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (1) (2024)
Xiang Li, Yangzhong Zhou, Bing Xu, Yunhe Qin, Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li
Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (1) (2024)
Xiang Li, Yangzhong Zhou, Bing Xu, Yunhe Qin, Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li
Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (1) (2024)
Xiang Li, Yangzhong Zhou, Bing Xu, Yunhe Qin, Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li
Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (1) (2024)
Xiang Li, Yangzhong Zhou, Bing Xu, Yunhe Qin, Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li
Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (1) (2024)
Hui Jiang, Yangzhong Zhou
The vanishing touch: Unveiling the tuft erosion in scleroderma. Rheumatology and immunology research 5 (1) (2024)
Yangzhong Zhou, Chaojun Hu, Wanting Qi, Yin Long, Can Huang, Qian Wang, Xinping Tian, Jiu-Liang Zhao, Mengtao Li, Xiao-Feng Zeng
Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China. Lupus science & medicine 10 (2) (2023)